• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去铁胺和去铁酮(L1)对MG-63骨细胞增殖及碱性磷酸酶活性的影响。

Effect of desferrioxamine and deferiprone (L1) on the proliferation of MG-63 bone cells and on phosphatase alkaline activity.

作者信息

Naves Díaz M L, Elorriaga R, Canteros A, Cannata Andía J B

机构信息

Instituto Reina Sofía de Investigación Nefrológica, Hospital Central de Asturias, Departamento de Medicina, Universidad de Oviedo, Spain.

出版信息

Nephrol Dial Transplant. 1998;13 Suppl 3:23-8. doi: 10.1093/ndt/13.suppl_3.23.

DOI:10.1093/ndt/13.suppl_3.23
PMID:9568816
Abstract

In the present work, we studied: (i) the effect of different doses of desferrioxamine and deferiprone on the proliferation of osteoblasts and the possible role of iron in this; and (ii) the effect of both chelators on the metabolic activity of these cells, using the quantification of alkaline phosphatase as an enzymatic marker of cellular activity or differentiation. Cellular proliferation was investigated at different concentrations of deferiprone and desferrioxamine, and the effect of the addition of iron citrate on this proliferation was measured. The production of alkaline phosphatase after incubation with deferiprone (150 and 300 microM) and desferrioxamine (20 and 100 microM) was also studied. Cellular proliferation was completely inhibited with 100 microM of desferrioxamine and 300 microM of deferiprone. In both cases, this effect was corrected by means of co-incubation with iron citrate. In the second phase, using the same dose that inhibited the proliferation, it was observed that after 24 h, both chelators slightly decreased alkaline phosphatase activity, while at 48 and 96 h they increased alkaline phosphatase activity. These results demonstrate that both desferrioxamine and deferiprone inhibit the proliferation of the osteoblast-like cell line MG-63; the effect seems to be related to the chelation of some fraction of available iron. In spite of the effect on bone cell proliferation, the chelators do not impair cellular activity.

摘要

在本研究中,我们研究了:(i)不同剂量的去铁胺和地拉罗司对成骨细胞增殖的影响以及铁在其中可能发挥的作用;(ii)使用碱性磷酸酶定量作为细胞活性或分化的酶标志物,研究这两种螯合剂对这些细胞代谢活性的影响。研究了不同浓度的地拉罗司和去铁胺对细胞增殖的影响,并测定了添加柠檬酸铁对这种增殖的作用。还研究了用150和300微摩尔/升的地拉罗司以及20和100微摩尔/升的去铁胺孵育后碱性磷酸酶的产生情况。100微摩尔/升的去铁胺和300微摩尔/升的地拉罗司完全抑制了细胞增殖。在这两种情况下,通过与柠檬酸铁共同孵育可纠正这种作用。在第二阶段,使用抑制增殖的相同剂量,观察到24小时后,两种螯合剂均轻微降低了碱性磷酸酶活性,而在48小时和96小时时它们增加了碱性磷酸酶活性。这些结果表明,去铁胺和地拉罗司均抑制成骨样细胞系MG-63的增殖;这种作用似乎与螯合一部分可利用铁有关。尽管对骨细胞增殖有影响,但螯合剂并不损害细胞活性。

相似文献

1
Effect of desferrioxamine and deferiprone (L1) on the proliferation of MG-63 bone cells and on phosphatase alkaline activity.去铁胺和去铁酮(L1)对MG-63骨细胞增殖及碱性磷酸酶活性的影响。
Nephrol Dial Transplant. 1998;13 Suppl 3:23-8. doi: 10.1093/ndt/13.suppl_3.23.
2
[Effect of desferrioxamine and deferiprone on osteocalcin secretion in osteoblast-type cells].
Nefrologia. 2003;23 Suppl 2:27-31.
3
Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs.去铁胺、地拉罗司及其他铁和铝螯合药物的疗效与毒性比较
Toxicol Lett. 1995 Oct;80(1-3):1-18. doi: 10.1016/0378-4274(95)03415-h.
4
Antiproliferative effect of deferiprone on the Hep G2 cell line.去铁酮对Hep G2细胞系的抗增殖作用。
Biochem Pharmacol. 1998 Aug 15;56(4):431-7. doi: 10.1016/s0006-2952(98)00071-9.
5
Antiproliferative and apoptotic effects of iron chelators on human cervical carcinoma cells.铁螯合剂对人宫颈癌细胞的抗增殖和凋亡作用。
Gynecol Oncol. 2002 Apr;85(1):95-102. doi: 10.1006/gyno.2001.6570.
6
Iron chelators induce apoptosis in proliferating cells.铁螯合剂可诱导增殖细胞凋亡。
Br J Haematol. 1995 Jan;89(1):181-7. doi: 10.1111/j.1365-2141.1995.tb08927.x.
7
Chelation therapy and bone metabolism markers in thalassemia major.重型地中海贫血中的螯合疗法与骨代谢标志物
J Pediatr Endocrinol Metab. 2006 Nov;19(11):1335-42. doi: 10.1515/jpem.2006.19.11.1335.
8
Binding of aluminium to plasma proteins: comparative effect of desferrioxamine and deferiprone (L1).
Clin Chim Acta. 1994 Oct 31;230(2):137-45. doi: 10.1016/0009-8981(94)90266-6.
9
The effect of deferiprone (L1) and desferrioxamine on myelopoiesis using a liquid culture system.
Br J Haematol. 1994 May;87(1):196-8. doi: 10.1111/j.1365-2141.1994.tb04892.x.
10
Radiation sensitization of mammalian cells by metal chelators.金属螯合剂对哺乳动物细胞的辐射增敏作用。
Radiat Res. 2001 Feb;155(2):304-10. doi: 10.1667/0033-7587(2001)155[0304:rsomcb]2.0.co;2.

引用本文的文献

1
Advanced therapeutic scaffolds of biomimetic periosteum for functional bone regeneration.用于功能性骨再生的仿生骨膜高级治疗支架
J Nanobiotechnology. 2025 Jul 26;23(1):542. doi: 10.1186/s12951-025-03614-5.
2
The Role of Ferroptosis in Osteoporosis and Advances in Chinese Herbal Interventions.铁死亡在骨质疏松症中的作用及中药干预研究进展
Biology (Basel). 2025 Apr 2;14(4):367. doi: 10.3390/biology14040367.
3
Mechanism and application prospect of ferroptosis inhibitors in improving osteoporosis.铁死亡抑制剂改善骨质疏松症的机制及应用前景
Front Endocrinol (Lausanne). 2024 Dec 13;15:1492610. doi: 10.3389/fendo.2024.1492610. eCollection 2024.
4
Investigation of the activity of a novel tropolone in osteosarcoma.一种新型托酚酮在骨肉瘤中的活性研究。
Drug Dev Res. 2024 Feb;85(1):e22129. doi: 10.1002/ddr.22129. Epub 2023 Nov 14.
5
Wnt5a is a key target for the pro-osteogenic effects of iron chelation on osteoblast progenitors.Wnt5a是铁螯合对成骨祖细胞促骨生成作用的关键靶点。
Haematologica. 2016 Dec;101(12):1499-1507. doi: 10.3324/haematol.2016.144808. Epub 2016 Aug 18.
6
Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts.缺氧可降低成骨细胞中骨硬化蛋白的表达,增加 Wnt 信号通路。
J Cell Biochem. 2010 May 15;110(2):457-67. doi: 10.1002/jcb.22559.
7
Deferiprone: a review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion-dependent diseases.去铁酮:对其在重型β地中海贫血及其他依赖输血疾病的铁过载中临床潜力的综述
Drugs. 1999 Sep;58(3):553-78. doi: 10.2165/00003495-199958030-00021.